Differential diagnosis of chronic tonsillitis in frequently ill children

Chronic tonsillitis is one of the most common pathologies of the lymphoepithelial pharyngeal ring. The main pathogen in chronic tonsillitis and its complications is group a β-hemolytic Streptococcus A (BGSA). This pathogen is detected in 30–60% of patients. At the present stage, the role of latent viral infections (Epstein – Barr virus (EBV), cytomegalovirus (CMV)) in the formation of chronic tonsillitis in children has been proven. Treatment of frequently ill children with pathology of the pharyngeal lymphoid ring remains an urgent and widely discussed issue. Depending on the etiology and clinical form of chronic tonsillitis (simple, toxicallergic form (TAF I or II), the choice is between conservative methods and radical surgical treatment. Surgical treatment of chronic tonsillitis in children is recommended only if there are absolute indications. To standard methods of conservative treatment, such as sanation of lacunae of the tonsils with antiseptic solutions, the appointment of physiotherapy, funds for the correction of systemic and local immunity are actively used. In Pediatrics, the safe and optimal complex of effects of the herbal medicinal product Tonsilgon N is widely used. Based on the analysis of clinical observations of frequently ill children with chronic tonsillitis, the effectiveness of the herbal medicine Tonsilgon H (in monotherapy mode) was revealed. As a result, the expediency of using the drug Tonsilgon H in the treatment of compensated forms of chronic tonsillitis in frequently and long-term ill children was established. There was a significant decrease in the frequency of acute respiratory infections and, consequently, the risk of transition to a decompensated form of chronic tonsillitis.

1. Preobrazhenskii B.S., Popova G.N. Angina, chronic tonsillitis and related diseases. Moscow: Medgiz; 1970. (In Russ.)

2. Maltseva G.S. The role of group A beta-hemolytic streptococcus in tonsillar pathology. Rossiyskaya Otorinolaringologiya = Russian Otorhinolaryngology. 2007;(3):131–139. (In Russ.) Available at: http://entru.org/en/2007-3.html.

3. Piskunov V.S., Nikitin N.A. Experience of the usage of Tonsilgon® N in the complex treatment of chronic tonsillitis with irrigations of palatine tonsils in adults. Consilium Medicum. 2018;20(3):48–52. (In Russ.) doi: 10.26442/2075-1753_20.3.48-52.

4. Kosyakov S.Y., Agnotoeva I.B., Muldasheva A.A. The contradictory nature of current views on the problem of chronic tonsillitis. Meditsinskiy sovet = Medical Council. 2015;(3):35–39. (In Russ.) doi: 10.21518/2079-701X-2015-3-35-39.

5. Zautner A.E., Krause M., Stropahl G., Holtfreter S., Frickmann H., Maletzki C. et al. Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS One. 2010;5(3):e9452. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830486/.

6. Thornton R., Richmond P., Vijayasekaran S., Rigby P., Wiertsema S., Coates H. A New Disease Paradigm – Mucosal and stromal intracellular bacteria in the upper respiratory tract. Laryngoscope. 2009;119(S3):322. doi: 10.1002/lary.21588.

7. Kasenõmm P., Piirsoo A., Kull M., Mikelsaar M. Selection of indicators for tonsillectomy in adults with recurrent tonsillitis. BMC Ear, Nose and Throat Disorders. 2005;5:7. doi: 10.1186/1472-6815-5-7.

8. Yanov Yu.K., Maltseva G.S., Drozdova M.V., Zakharova G.P., Grinchuk O.N. The choice of the treatment strategy for the patients presenting with chronic tonsillitis of streptococcal etiology and subfebrility of long duration. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2019;84(1):64–67. (In Russ.). doi: 10.17116/otorino20198401164.

9. Palchun V.T. Classification and therapeutic strategy for chronic tonsillitis. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2013;78(3):8– 11. (In Russ.). Available at: https://www.mediasphera.ru/issues/vestnikotorinolaringologii/2013/3/030042-4668201332.

10. Ruiz J., Doron S.; Aronson M.A., Sokol N.H. (eds.). Тоnsillectomy in adults: Indication. 2011. Available at: https://somepomed.org/articulos/contents/mobipreview.htm?18/5/18512/contributor-disclosure.

11. Klug T.E. Incidence and microbiology of peritonsillar abscess: the influence of season, age, and gender. Eur J Clin Microbiol Infect Dis. 2014;33(7):1163–1167. doi: 10.1007/s10096-014-2052-8.

12. Ryazantsev S.V., Krivopalov A.A., Eremin S.A. Features of nonspecific prevention and treatment of patients with exacerbation of chronic tonsillitis. RMZH = RMJ. 2017;(23):1688–1694. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Osobennosti_nespecificheskoy_profilaktiki_i_lecheniya_pacientov_s_obostreniem_hronicheskogo_tonzillita.

13. Preobrazhenskaja Y.S., Drozdova M.V. Treatment of patients with pathology of lymphepithelial pharyngeal ring, complicated by the otitis media with effusion. Rossiyskaya Otorinolaringologiya = Russian Otorhinolaryngology. 2014;3(70):89–96 (In Russ.) Available at: https://elibrary.ru/item.asp?id=21801513.

14. Srinivasan A., Gu Z., Smith T., Morgenstern M., Sunkara A., Kang G. et al. Prospective detection of respiratory pathogens in symptomatic children with cancer. Pediatr Infect Dis J. 2013;32(3):e99–e104. doi: 10.1097/INF.0b013e31827bd619.

15. Saltanova Zh.E. Chronic tonsillitis, etiological and pathogenetic aspects of the development of metatonsillar complications. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2015;80(3):65–70. (In Russ.) doi: 10.17116/otorino201580365-70.

16. Acar G.Ö., Cansz H., Duman C., Öz B., Ciğercioğullar E. Excessive reactive lymphoid hyperplasia in a child with persistent obstructive sleep apnea despite previous tonsillectomy and adenoidectomy. J Craniofac Surg. 2011;22(4):1413–1415. doi: 10.1097/SCS.0b013e31821cc528.

17. Drozdova M.V., Maltceva G.S., Tirnova E.V. Preoperative screening for the hemostatic system in ENT surgery in children. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2019;84(2):18–22. (In Russ.) doi: 10.17116/otorino2019840211.

18. Drozdova M.V., Tirnova E.V., Yanov Y.K. Clinikal and laboratory diagnosis of lymphoproliferative disorder in children. St Petersburg; St Petersburg Research Institute of Ear, Throat, Nose and Speech; 2009. 32 p. (In Russ.). Available at: https://elibrary.ru/item.asp?id=25849610.

19. Drozdova M.V., Ochilov R.T., Tirnova E.V., Artyushkin S.A. Disorders of the hemostasis system during surgery at the children with lymphepithelial ring chronic pathology. Rossiyskaya Otorinolaringologiya = Russian Otorhinolaryngology. 2013;(6):39–44. (In Russ.) Available at: https://elibrary.ru/item.asp?id=21080546.

20. Kryukov A.I., Zayratyants O.V., Tsarapkin G.Yu., Ivoilov A.Yu., Kucherov A.G., Tovmasyan A.S. et al. Age features of the vascular organization of the adenoid tissue. Morfologicheskie vedomosti = Morphological Newsletter. 2017;25(2):32–36. (In Russ.) doi: 10.20340/mv-mn.17(25).02.05.

21. Francis D.O., Fonnesbeck C., Sathe N., McPheeters M., Krishnaswami S., Chinnadurai S. Postoperative bleeding and associated utilization following tonsillectomy in children. Otolaryngol Head Neck Surg. 2017;156(3):442–455. doi: 10.1177/0194599816683915.

22. Drozdova M.V., Preobrazhenskaya Yu.S., Tyrnova E.V., Larionova S.N. Features of etiological diagnosis of lymphoproliferative syndrome in children. RMZH = RMJ. 2018;(10(II)):63–67. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Osobennosti_etiologicheskoy_diagnostiki_limfoproliferativnogo_sindroma_udetey/.

23. Khaldin A.A., Nasyrova Eh.I. The possibility of using immunomodulators for treatment of herpes virus diseases from the viewpoint of immunopathogenesis of infectious processes. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2018;17(5):134–140. (In Russ.) doi: 10.17116/klinderma201817051134.

24. Tyrnova E.V., Maltseva G.S. Clinical biochemistry methods in the diagnosis of chronic tonsillitis. Rossiyskaya Otorinolaringologiya = Russian Otorhinolaryngology. 2005;4(17):108–111. (In Russ.) Available at: https://elibrary.ru/item.asp?id=36400752.

25. Simark-Mattsson C., Dahlgren U., Roos K. CD4+CD25+ T lymphocytes in human tonsils suppress the proliferation of CD4+CD25-tonsil cells. Scand J Immunol. 2002;55(6):606–611. doi: 10.1046/j.1365-3083.2002.01095.x.

26. Logunova E.V., Egorov V.I., Nasedkin A.N., Rusanova E.V. The use of the enzymes for the enhancement of the effectiveness of antimicrobial photodynamic treatment of the patients presenting with chronic tonsillitis. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2016;81(2):44– 48. (In Russ.) doi: 10.17116/otorino201681244-48.

27. Vavilova V.P., Abramov-Sommariva D., Steindl H., Wonnemann M., Ryzhova E.G., Rusova T.V. et al. Clinical effectiveness and tolerability of Tonsilgon®N in the treatment of recurrent upper respiratory tract infections in children: a non-interventional study in Russia. RMZH = RMJ. 2017;(5):350–358. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Klinicheskaya_effektivnosty_i_perenosimosty_preparata_Tonzilgon_N_pri_lechenii_recidiviruyuschih_infekciy_verhnih_dyhatelynyh_putey_u_detey_neintervencionnoe_issledovanie_v_Rossii/#ixzz6Y65PScwW.

28. Ryazancev S.V., Drozdova M.V. The experience of administration of the preparation Tonsilgon N in treatment of chronic tonsillitis in sickly children. Rossiyskaya Otorinolaringologiya = Russian Otorhinolaryngology. 2016;5(84):120–125. (In Russ.) doi: 10.18692/1810-4800-2016-5-120-125.

29. Gurov A.V., Yushkina M.A. Opportunities of Tonsilgon® N use in complex treatment of chronic tonsillitis. Consilium Medicum. 2018;20(11):20–24. (In Russ.) Available at: https://cyberleninka.ru/article/n/vozmozhnosti-primeneniya-preparata-tonzilgon-n-v-kompleksnoy-terapii-hronicheskogotonzillita/viewer.